QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
22.48
-1.13 (-4.79%)
At close: Feb 20, 2026, 4:00 PM EST
22.85
+0.37 (1.65%)
After-hours: Feb 20, 2026, 7:38 PM EST
QuidelOrtho Employees
QuidelOrtho had 6,600 employees as of December 29, 2024. The number of employees decreased by 500 or -7.04% compared to the previous year.
Employees
6,600
Change (1Y)
-500
Growth (1Y)
-7.04%
Revenue / Employee
$413,667
Profits / Employee
-$171,485
Market Cap
1.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 29, 2024 | 6,600 | -500 | -7.04% |
| Dec 31, 2023 | 7,100 | 100 | 1.43% |
| Jan 1, 2023 | 7,000 | 5,400 | 337.50% |
| Jan 2, 2022 | 1,600 | 230 | 16.79% |
| Jan 3, 2021 | 1,370 | 120 | 9.60% |
| Dec 31, 2019 | 1,250 | 26 | 2.12% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,500 |
| Enovis | 7,367 |
| UFP Technologies | 4,146 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,650 |
| Artivion | 1,600 |
| NovoCure | 1,488 |
| Inspire Medical Systems | 1,333 |
QDEL News
- 2 days ago - Faster Cardiac Answers with High‑Sensitivity Troponin - PRNewsWire
- 3 days ago - QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - PRNewsWire
- 10 days ago - QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 18 days ago - QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards - PRNewsWire
- 4 weeks ago - Strengthening the blood supply: Awareness, challenges and donor impact - PRNewsWire
- 4 weeks ago - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 2 months ago - Innovating Diagnostics and What's Next - PRNewsWire